LSPedia & Spring Bio Solution Partner to advance Pharma Traceability in India
Spring Bio Solution will offer LSPedia’s OneScan platform, a compliance and traceability solution designed to manage serialization, regulatory reporting, and drug verification requirements for pharmaceutical manufacturers and supply chain partners.
Headquartered in the United States, LSPedia, a pharmaceutical traceability technology provider, has partnered with Spring Bio Solution, a Mumbai-based comparator sourcing and clinical supplies company, to expand drug compliance and serialization solutions in India and other international markets.
As part of the partnership, Spring Bio Solution will lead LSPedia’s India entity from its headquarters in Mumbai.
The company also aims to support LSPedia’s expansion into Europe and Singapore.
Spring Bio Solution will offer LSPedia’s OneScan platform, a compliance and traceability solution designed to manage serialization, regulatory reporting, and drug verification requirements for pharmaceutical manufacturers and supply chain partners.
“Our collaboration with Spring Bio Solution strengthens our ability to deliver compliance innovation on a global scale,” said Daniel MacKinnon, Senior Vice President of LSPedia.
LSPedia develops cloud-based solutions to help pharmaceutical manufacturers and distributors meet global drug traceability and serialization requirements. Its OneScan suite is used to ensure compliance with regulatory mandates and improve supply chain security.
Spring Bio Solution, founded in Mumbai, provides services in comparator sourcing and clinical trial supplies. The company supports pharmaceutical companies in managing supply chain requirements for clinical studies and drug development.
“Spring Bio Solution has always prioritized client success by delivering innovative and reliable solutions,” said Salim Shaikh Sadiq, Founder of Spring Bio Solution.
“This partnership with LSPedia allows us to expand our offerings and empower pharmaceutical manufacturers with world-class compliance tools.”
The partnership will allow LSPedia to strengthen its presence in India and extend the availability of OneScan to pharmaceutical companies across additional global markets.
